LLY250117C1080000
- 0.01
- 0.000.00%
Eli Lilly and Co Newsroom
The demand for weight loss drugs has dragged down Eli Lilly and Co's Q4 performance, which may be worse than expected, while the revenue guidance exceeds expectations, and the stock price once fell nearly 9%.
Eli Lilly and Co released a performance report showing that the Q4 revenue forecast fell short of expectations. The company explained that the growth in demand for weight loss drugs was lower than anticipated, and insufficient inventory levels at the end of the year affected performance. This marks the second consecutive quarter that the company has missed sales targets due to forecast discrepancies. Analysts state that the market has extremely high growth expectations for Eli Lilly and Co, leaving almost no room for error. Despite optimism that revenue will reach between 58 billion and 61 billion dollars in 2025, exceeding market expectations, the stock price fell nearly 9% in early trading on Tuesday.
Express News | Eli Lilly and Co has attributed the decline in performance for the second consecutive quarter to inventory issues.
Demand for weight-loss drugs is below expectations, and Eli Lilly and Co's stock price has plummeted!
Lowering performance expectations leads to a significant drop in stock prices.
Microsoft, Applied Digital, Rigetti Computing, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Citi Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,250
BofA Securities Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $997
Futu Morning Report | USA's December PPI unexpectedly cools down! Wall Street nervously prepares for CPI release day; quantum computing stocks rebound strongly, RGTI surges 48%.
In December, the USA's PPI unexpectedly cooled, growing by 0.2% month-on-month. The year-on-year growth of the December PPI and core PPI were 3.3% and 3.5% respectively, both the highest growth rates since February 2023; Biden has signed another executive order to accelerate the development of AI infrastructure.
Jim Cramer Says He Supports Healthcare Stocks for Their Long-term Value
Top 20 by transaction volume | Bitcoin once reached over $97,000, MSTR rose over 4%; Technology stocks declined, with Tesla and NVIDIA falling over 1%.
On Tuesday, Meta Platforms, ranked 4th in U.S. stocks, closed down 2.31% with a transaction volume of 8.084 billion USD; Eli Lilly and Co, ranked 5th, closed down 6.58%, marking the largest single-day decline since March 2021, with a transaction volume of 7.702 billion USD; Quantum Computing concept stock Rigetti Computing, ranked 15th, closed up 47.93% with a transaction volume of 2.724 billion USD.
US stocks closed with mixed results | The three major Indexes had varied performances, Quantum Computing stocks rebounded sharply, with RGTI surging 48%; China Concept Stocks saw a general increase, with Xiaopeng Autos rising nearly 7%.
① The seven tech giants all fell, with Meta down more than 5%; ② China Concept Stocks collectively rose, with the Nasdaq China Golden Dragon Index up 2.10%; ③ Eli Lilly and Co fell 6.6%, marking its worst single-day performance since March 2021.
The three major U.S. stock indexes experienced mixed results, with the China Concept Index rising by 2.1% and Eli Lilly and Co falling by 6.6%.
On January 15th, Gelonghui reported that the three major U.S. stock indices closed mixed, with the Nasdaq down 0.23%, the S&P 500 Index up 0.11%, and the Dow Jones up 0.52%. Most large Technology stocks declined, with Tesla, NVIDIA, and Netflix each dropping over 1%. Meta fell by more than 2%, as the company plans to lay off 5% of low-performing employees. Eli Lilly and Co closed down 6.6%, marking its worst single-day performance since March 2021, as the company forecasts weak sales for weight-loss drugs in the fourth quarter. The Nasdaq China Golden Dragon Index increased by 2.1%, with China Concept Stocks rising broadly, including Xpeng Autos up over 6%, JD.com up over 4%, and Kingsoft Cloud and Bilibili each up over 3%.
Eli Lilly and Co Options Spot-On: On January 14th, 109.58K Contracts Were Traded, With 326.59K Open Interest
On January 14th ET, $Eli Lilly and Co(LLY.US)$ had active options trading, with a total trading volume of 109.58K options for the day, of which put options accounted for 40.72% of the total
Trending Stocks Today | Eterna Therapeutics Surges 66.76%
January 14th - US stocks trending in regular trading hours.Gainers: $Eterna Therapeutics(ERNA.US)$ soars 66.76% to $0.52 with a turnover of $401.2 million. $Firefly Neuroscience(AIFF.US)$ surges 67.21
Eli Lilly And Co. To Present At J.P. Morgan Healthcare Conference; Webcast At 5:15 PM ET
JNJ, GSK, LLY Announce M&A Deals at JP Morgan Conference
ETF Earnings: Biggest Weeks for Major Funds as Holdings Report
Sector Update: Health Care Stocks Fall Tuesday Afternoon
Jefferies Adjusts Price Target on Eli Lilly to $996 From $994
Sector Update: Health Care
Top Midday Decliners